Core Insights:
The World Health Organization Framework Convention on Tobacco Control (FCTC) is facing a fundamental route split. The 11th Conference of the Parties (COP-11) has evolved into a key battlefield for two opposing public health philosophies: one is an ideologically driven policy represented by Belgium, which adheres to traditional prohibitions; the other side is led by the UK, advocating for innovative strategies based on scientific evidence for tobacco harm reduction (THR). The outcome of this meeting will not only affect the regulatory direction of nicotine products worldwide, but also test the credibility and future direction of the World Health Organization in the field of public health.
Driving Factors:
- Deep Ideological Opposition: The core disagreement in global tobacco control strategies lies in whether to view new nicotine products such as e-cigarettes as a public health threat (Belgian stance) or as an effective tool to help smokers quit and reduce health risks (UK stance).
- The Bottleneck of the Effectiveness of Traditional Policies: Despite decades of strict regulation, 7.5 million people worldwide still die from smoking every year. Countries such as Belgium that have adopted a ban strategy still have a high smoking rate of around 20%, demonstrating the limitations of traditional methods.
- Successful Demonstration of Harm Reduction Strategies: Countries represented by the UK and Sweden have achieved record low smoking rates by promoting less harmful alternatives such as electronic cigarettes. These successful cases provide strong practical evidence for the “harm reduction” strategy and challenge the authority of injunctions.
- Closed and Rigid Decision-Making Mechanism: The COP conference has been criticized as a “secret closed safe deposit box” with a lack of transparency in its decision-making process and exclusion of independent scientists and consumer representatives. This ‘groupthink’ leads to its adherence to outdated policies and slow response to innovation and new evidence.
Key Evidence:
- National Stance Confrontation: Belgium will hold a global seminar against new nicotine products during COP-11; The UK Department of Health has explicitly stated that its delegation will once again emphasize that “the harm of electronic cigarettes is far less than that of smoking, and they are an effective tool to help adult smokers quit smoking”.
- Policy Effect Contrast: Despite implementing extensive restriction measures, Belgium’s smoking rate “still remains at around 20%, one of the highest in Western Europe”. In contrast, countries such as the UK have achieved significant results through harm reduction methods.
- The Official Inclination of the World Health Organization: According to reports, the briefing document prepared by the WHO Secretariat for agenda item 4.5 “completely negates harm reduction methods” and its agenda is filled with traditional measures such as new bans, lawsuits, and stricter product restrictions.
- Expert Warning: Policy analyst Clive Bates warns in his COP-11 Representative Survival Guide that the current direction of FCTC “carries the risk of solidification failure” and points out that embracing harm reduction is the “only viable path forward”.
- Lack of Transparency: The COP conference only recognizes 29 observer organizations, while the United Nations Climate Conference has over 4000. This exclusivity has sparked accusations of its ‘scientific isolation’.
Strategic Insights:
COP-11 marks a decisive turning point in global tobacco control strategies. This is no longer a simple policy adjustment, but a fundamental contest about the balance between “ideology” and “scientific effectiveness”. If FCTC continues to adhere to injunctions and ignore the enormous public health potential brought by harm reduction innovation, it will not only miss the opportunity to save millions of lives, but may also lose its moral authority and leadership position in global health governance as a result. Ultimately, history will remember that innovation, not prohibition, saves lives.

